Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
about
Contemporary assessment and pharmacotherapy of Tourette syndromeDiagnosis and treatment of dystoniaCurrent and emerging strategies for treatment of childhood dystoniaTetrabenazine: Spotlight on Drug Review.Sulpiride-induced tardive dystoniaEuropean clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatmentCurrent and future medical treatment in primary dystonia.Efficacy of pharmacological treatment of dystonia: evidence-based review including meta-analysis of the effect of botulinum toxin and other cure options.Tics in the Pediatric Population: Pragmatic ManagementTetrabenazine for the treatment of tardive dyskinesia.Treatment strategies for dystonia.Neuroleptic malignant syndrome: mechanisms, interactions, and causality.Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia.Tetrabenazine for hyperglycemic-induced hemichorea-hemiballismus.Tetrabenazine in the treatment of Huntington's diseaseThe treatment of Tourette's syndrome: current opinions.A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatment.Tourette's syndrome and role of tetrabenazine: review and personal experience.Emerging treatments for Tourette's disorder.Parkinsonism and tremor disorders. A clinical approach.Movement disorders after stroke.Tourette's Syndrome in Children.Pathophysiology of pediatric movement disorders.Drug-induced movement disorders in children and adolescents.Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.Abnormal motor function and dopamine neurotransmission in DYT1 DeltaGAG transgenic mice.The management of cervical dystonia.Approaches to the development of medications for the treatment of methamphetamine dependence.Botulinum toxin treatment of axial and cervical dystonia.Symptomatic treatment of Huntington diseaseThe current clinical management of Huntington's disease.Tetrabenazine improves levodopa-induced peak-dose dyskinesias in patients with Parkinson's diseaseSafety and Efficacy of Tetrabenazine and Use of Concomitant Medications During Long-Term, Open-Label Treatment of Chorea Associated with Huntington's and Other Diseases.Emerging drug therapies in Huntington's disease.Tetrabenazine.Tardive dyskinesia in patients treated with atypical antipsychotics: case series and brief review of etiologic and treatment considerations.An update on Tourette syndrome.Update on the Non-Huntington's Disease Choreas with Comments on the Current NomenclaturePost-stroke Movement Disorders: Clinical Manifestations and Pharmacological Management.Dopamine and Huntington's disease.
P2860
Q24607941-91C2F355-8863-40F6-882A-873DDFF5DC6AQ26830473-F2FD7732-692D-49CD-AE2D-1752EF25B849Q27011677-4031F06F-0E6D-49EB-8259-768AA895610FQ27692599-E8430FF5-BDC3-4922-ACE8-5C23807F419CQ28334124-07EDFD17-4489-4EF3-8EE1-648CD008770DQ28972478-52BD908C-BADE-480F-9B06-55B229C2D537Q30465848-FAB870CD-3314-451B-98A1-42E345FEEE3AQ31069022-56AFA982-1E6C-4A89-AA24-B167D1763617Q33577672-33184FD5-CC3B-4A9E-971E-CF4BF7F7677CQ33870853-E611462F-ECA9-4C37-B325-234545668EBCQ34087402-8D042830-53CC-4162-85A1-13A9A86C335CQ34125579-2A7778D1-5F0C-4E3F-85C0-13141B152278Q34522634-11523091-7C0E-4ABD-BAB5-3AA8E7AA2167Q34567334-B487A956-048F-4D4E-A005-323C98C715E4Q34606748-36D28088-3949-4737-99C4-4E61EFE5DE9AQ34706905-10435788-DEEA-429C-BD31-8E42223D4766Q34738902-0F91A203-825C-4A97-B8A0-5571EF0946C5Q34785783-A90AA505-4CED-430B-89DD-265F3756040BQ34796193-57761A08-2B3D-4E95-A989-C946B31E23D1Q34804035-3F2CDF38-03C5-496E-9630-80DD4E9B3915Q34960517-39269679-D18B-4125-B9EB-7C6441D41ABFQ35147283-42DABDEA-C48F-4949-ADD4-1509AF7399B0Q35292297-D1F0A543-1726-48C4-9E5A-C51A1FACFE40Q36040766-4FF28B80-1A7B-492F-831A-EE9A5D31CAE4Q36370626-F617E4E4-361A-4E60-9C77-305C66A08A91Q36666604-96B20D5F-E3DD-4AC9-A80E-400E8C44A913Q36719664-3AE1C238-3671-4BCC-9572-8BC9A635F5BBQ36817245-7AC03E00-9467-44EA-A77A-4F1E44C6D5F0Q37011514-DDFCB3C8-6C7A-4EBC-AE5E-2D7AEFAACFDAQ37131233-C52811CB-9AC7-4E19-B628-F09C31F87616Q37200714-EBE330F7-24EC-4617-8312-84DE24124F4FQ37267145-BD407A97-AA61-40F1-9EEE-602071EDA27CQ37292551-C7579FFC-C90B-4FA1-98EE-4BB50EEA6B2BQ37488273-1827BB58-49BA-4603-AF73-1E3AD39A54B8Q37636156-832F867B-C7AA-4F2D-9B0D-328D6435351DQ37707292-AAFD451B-709A-479C-BD65-C3F449A19CB9Q37743276-8EE4732E-A4FF-43D6-89BD-409DE87089BAQ38084611-CFB611A4-4DA4-49C4-AFAF-97E78CFADCDBQ38085546-ABE250DA-19B4-422A-8FF9-5D2CEB16A4E5Q38379277-0BE49804-414D-46A7-B7C1-9975DCC59F0B
P2860
Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
description
1988 nî lūn-bûn
@nan
1988 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի մարտին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
@ast
Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
@en
Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
@nl
type
label
Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
@ast
Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
@en
Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
@nl
prefLabel
Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
@ast
Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
@en
Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
@nl
P356
P1433
P1476
Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
@en
P2093
P304
P356
10.1212/WNL.38.3.391
P407
P577
1988-03-01T00:00:00Z